BRIEF published on 04/23/2026 at 15:15, 5 months 11 days ago Newron Pharmaceuticals Announces AGM 2026 Results Board Members Newron Pharmaceuticals Evenamide AGM 2026 Xadago®
PRESS RELEASE published on 04/23/2026 at 15:10, 5 months 11 days ago Newron announces AGM 2026 results Newron Pharmaceuticals S.p.A. announces successful AGM 2026 results including new Board members. Focus on developing therapies for nervous system diseases Board Members Newron Pharmaceuticals Thérapies AGM 2026 Nervous System Diseases
BRIEF published on 03/24/2026 at 07:05, 6 months 11 days ago Newron Announces 2025 Results and 2026 Outlook Financial Results Schizophrenia Treatment Patent Grant 2026 Outlook Evenamide Trials
BRIEF published on 03/24/2026 at 07:05, 6 months 11 days ago Newron annonce ses résultats pour 2025 et ses perspectives pour 2026. Résultats Financiers Traitement De La Schizophrénie Perspectives Pour 2026 Brevet Accordé Essais Sur L'Evenamide
PRESS RELEASE published on 03/24/2026 at 07:00, 6 months 11 days ago Newron presents 2025 financial results and provides 2026 outlook Newron Pharmaceuticals S.p.A. presents 2025 financial results and 2026 outlook, including progress on evenamide clinical trials and IP expansion Financial Results Clinical Trials Newron Pharmaceuticals 2026 Outlook IP Expansion
BRIEF published on 03/20/2026 at 07:05, 6 months 15 days ago Newron Pharmaceuticals présentera ses travaux au SIRS 2026 Newron Pharmaceuticals Evenamide Schizophrénie Résistante Au Traitement Modulation Du Glutamate Recherche Sur La Schizophrénie
BRIEF published on 03/20/2026 at 07:05, 6 months 15 days ago Newron Pharmaceuticals to Present at SIRS 2026 Newron Pharmaceuticals Evenamide Treatment-resistant Schizophrenia Glutamate Modulation Schizophrenia Research
PRESS RELEASE published on 03/20/2026 at 07:00, 6 months 15 days ago Newron to present at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS) Newron Pharmaceuticals S.p.A. to present at SIRS 2026 Congress on glutamatergic modulation in treatment-resistant schizophrenia Schizophrenia Newron Pharmaceuticals Congress Glutamatergic Modulation SIRS
BRIEF published on 03/19/2026 at 07:05, 6 months 16 days ago Newron Pharmaceuticals Extends Loan Repayment with EIB European Investment Bank Newron Pharmaceuticals Evenamide Finance Contract ENIGMA-TRS Phase III
BRIEF published on 03/19/2026 at 07:05, 6 months 16 days ago Newron Pharmaceuticals prolonge le remboursement de son prêt auprès de la BEI Newron Pharmaceuticals Evenamide Banque Européenne D'investissement Contrat Financier ENIGMA-TRS Phase III
Published on 10/03/2026 at 02:35, 1 day 17 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 6 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 7 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 7 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 14 hours 10 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 15 hours ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 4 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 20 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 23 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 2 days 2 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 2 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 2 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 2 hours ago Aéroports de Paris SA - Calendrier financier 2027
